Pulmonx Reports First Quarter 2025 Financial Results
1. Pulmonx Q1 2025 revenue reached $22.5 million, a 20% increase. 2. International revenue grew 39% year-over-year to $8.3 million. 3. U.S. revenue increased 11% to $14.2 million in Q1 2025. 4. Company reaffirmed 2025 revenue guidance of $96-98 million. 5. DOJ declined to intervene in ongoing investigation against Pulmonx.